Open AccessNo Greater Incidence or Worsening of Cardiac Valve Regurgitation with Somatostatin Analog Treatment of Acromegaly
Author(s) -
Annamaria Colao,
J Marek,
Miklós Góth,
Philippe Caron,
Jean Marc Kuhn,
Francesco Minuto,
Neil J. Weissman
Publication year - 2008
Publication title -
the journal of clinical endocrinology and metabolism
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.206
H-Index - 353
eISSN - 1945-7197
pISSN - 0021-972X
DOI - 10.1210/jc.2007-2199
Subject(s) - medicine , lanreotide , acromegaly , cardiology , prospective cohort study , population , odds ratio , relative risk , cohort , context (archaeology) , surgery , confidence interval , growth hormone , environmental health , hormone , paleontology , biology
Excess GH and IGF-I in acromegaly are associated with reduced life expectancy due to cardiovascular complications.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom